Discover trends, market shifts, and competitive outlooks for the preclinical imaging industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Are the Projected Market Size and Growth Rates for the Preclinical Imaging Market From 2025 To 2029?
The market size of preclinical imaging has seen considerable growth in the past few years. It is expected to increase from $3.46 billion in 2024 and reach $3.69 billion in 2025, with a compound annual growth rate (CAGR) of 6.7%. The significant growth in the past can be linked to governmental initiatives, a rising incidence of diseases, wider applications, growing consciousness, and expansion into emerging markets.
The market size for preclinical imaging is forecasted to experience notable expansion in the coming years, reaching $4.83 billion in 2029 with a compound annual growth rate (CAGR) of 6.9%. This expected surge in the prediction period can be linked to factors such as the increased acceptance of personalized medicine, advancements in molecular imaging, outsourcing of drug development, supportive regulatory environment, and the escalating prevalence of chronic diseases. Significant trends during the prediction period are anticipated to encompass green imaging technologies, technological progression, augmented R&D activities, collaborations and alliances, and real-time imaging.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp
What Are the Major Market Drivers Behind the Rising Adoption of Preclinical Imaging Market?
The rising prevalence of chronic diseases is predicted to fuel the expansion of the preclinical imaging market. Chronic diseases are long-term health issues that persist for an extended duration, generally three months or more. These illnesses often necessitate continuous medical care and can dramatically affect an individual’s quality of life. Preclinical imaging tools are utilized to detect chronic diseases, providing visuals of bone structure and lung function. Furthermore, they help in studying chronic diseases, enabling visualization of disease progression and enhancing disease comprehension. For instance, as per the highlights of the World Health Organization (WHO) in September 2022, a Switzerland-based intergovernmental health organization reported that chronic diseases or Noncommunicable diseases (NCDs) cause 41 million deaths annually, accounting for 74% of all deaths worldwide. This includes 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Hence, the surge in chronic diseases is propelling the growth of the preclinical imaging market.
Which Key Market Segments Comprise the Preclinical Imaging Market and Drive Its Revenue Growth?
The preclinical imaging market covered in this report is segmented –
1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-Magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-Computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems
2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents
3) By End User: Hospital, Diagnostics Center, Other End-User
Subsegments:
1) By Optical Imaging Systems: Bioluminescence Imaging, Fluorescence Imaging
2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT)
3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems, Functional Micro-MRI Systems
4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging, Real-Time Micro-Ultrasound Systems
5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems, Ex Vivo Micro-CT Systems
6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging, Hybrid Photoacoustic Imaging Systems
7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking, MPI For Vascular Imaging
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=12393&type=smp
Which Areas Are Leading Regions in the Preclinical Imaging Market Expansion Across the Globe?
North America was the largest region in the preclinical imaging market in 2024. The regions covered in the preclinical imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Are the Strategic Trends Steering thePreclinical Imaging Market Direction?
A significant emerging trend in the preclinical imaging sector is the creation of innovative products. Leading businesses within the market, such as Fujifilm VisualSonics Inc., a Canada-based biomedical firm specializing in imaging systems, are introducing groundbreaking products to maintain their market stand. For example, Vevo F2, a ground-breaking product designed for preclinical imaging, was released by Fujifilm VisualSonics in May 2022. It is the first ultra-high to low-frequency (71 MHz–1 MHz) ultrasonic and photoacoustic imaging system intended for preclinical use. The Vevo F2 boasts HD image processing capabilities, a brand-new signal pathway, and provides superior image clarity along with higher frame rates. It’s also designed to adapt to specific precision requirements of imaging. The additional features of this system include a fresh signal pathway, the ability to customize the system’s structure, high-resolution imaging, and the capacity to cover a broad range of anatomical targets. This system is apt for diverse research applications.
View the full report here:
https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report
How Is the Preclinical Imaging Market Conceptually Defined?
Preclinical imaging refers to the techniques used to visualize and study biological processes in animal models before being applied to human clinical trials. These imaging techniques allow researchers to track disease progression, evaluate the efficacy and safety of potential therapeutics, and gain insights into the biological mechanisms underlying diseases.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12393
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
